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Summary
We conducted two trials to evaluate the
effects of feeding graded levels of cloves to
weanling pigs as a substitute for anti-
microbials. In the first trial, improvements in
ADG were observed in pigs fed the lowest
level of clove addition (0.5%) and for those
fed carbadox (50 g/ton). The higher levels of
clove inclusion (1.0% and 2.0%) tended to
reduce feed intake.  A second trial was con-
ducted evaluating performance of pigs fed
diets containing 0.125%, 0.25% and 0.5%
cloves (a different batch than used in trial 1).
The was no ADG improvement from added
cloves as was observed in the first trial, and
the higher clove concentrations tended to
reduce feed intake. The inconsistent response
to added cloves between our two studies
merits further investigation. 
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Introduction
Public concern over the routine use of in-
feed antimicrobials continues to escalate.
These issues are due to concerns that routine
use of these antimicrobials contributes to
antibiotic resistance in humans. Cloves and
other spices have long been utilized as food
preservatives.   Many spices including cloves
have significant antimicrobial activity.
These established facts have prompted re-
searchers to investigate the potential of using
spices as substitutes for traditional anti-
microbials in animal feeds. Therefore, our
objective was to determine the effects of
feeding graded levels of cloves to weanling
pigs as a possible substitute for traditional
antimicrobials.  
Procedures
A total of 150 weanling pigs (averaging
13.9 lb in both studies) were used in each
study.  Pigs (PIC C22 × 326) were blocked
by initial weight, and randomly allotted to
one of the five dietary treatments in a ran-
domized complete block design.  Each pen
contained 5 pigs, and each trial included 6
replicates (pens) per treatment.
Experimental diets were fed in meal
form, and in two phases.  Phase 1 diets were
fed from d 0 to 7, and phase 2 diets were fed
from d 7 to 28.   Diets were formulated to
contain 1.55 % and 1.40 % total dietary
lysine for phases 1 and 2, respectively (Table
1).  Dietary energy, lysine, mineral, and
vitamin levels were held constant across
treatments within each dietary phase, and
across trials.  In the experimental diets, clove
or the feed antimicrobial replaced cornstarch.
Dietary treatments in Trial 1 included a
negative control (no antimicrobial or cloves),
a positive control (carbadox, 50 g/ton), and
three levels of cloves (0.5, 1.0, and 2.0%).
Trial 2 was completed with a similar treat-
ment structure, but had clove inclusions of
0.125%, 0.25% and 0.5%. In addition, the
cloves in this trial were obtained from a
different lot than used in Trial 1.
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Table 1.   Diet Composition (As-Fed Basis)a %
Item Phase 1 Basal Diet Phase 2 Basal Diet
Corn 47.21% 51.59%
Soybean meal (46.5%) 27.56% 31.51%
Monocalcium phosphate (21% P) 1.20% 1.70%
Limestone 0.95% 0.85%
Salt 0.35% 0.35%
Vitamin premix 0.25% 0.25%
Trace mineral premix 0.15% 0.15%
Sow add pack 0.05% 0.05%
Corn starch 2.00% 2.00%
L-threonine 0.00% 0.05%
Cloves 0.00% 0.00%
Carbadox 0.00% 0.00%
Lysine HCl 0.15% 0.15%
DL-methionine 0.13% 0.10%
Spray-dried porcine plasma 5.00% 1.25%
Spray dried whey 15.00% 10.00%
aClove or carbadox was provided at the expense of cornstarch to provide the clove or positive
control diets. 
Pigs were weighed and feed disappear-
ance was measured weekly to determine
ADG, ADFI, and F/G. Data were analyzed
using GLM procedures of SAS in a random-
ized complete block design.
Results and Discussion
In trial 1 from d 0 to 21, ADG was im-
proved (P<0.05) for the pigs fed the diet
containing carbadox and the diet containing
0.5% cloves compared to those fed the nega-
tive control (Table 2). For the overall d 0 to
28 period, pigs fed 0.5% cloves tended (P<
.12) to have better ADG and d 28 average
weights compared to those fed the negative
control diet.  Pigs fed carbadox had
increased (P<0.04) ADG, ADFI, and day 28
average weight compared to the negative
control pigs for the overall 28-day evalua-
tion.
Average daily gain, ADFI, and 28-day
average weights decreased (P=0.05) in pigs
fed the 2.0% clove diet compared to pigs fed
either the positive or negative control diets.
The reduction in feed intake at the higher
levels of dietary clove inclusion may have
been due to the flavors associated with
cloves. 
Because improvements in ADG were
observed through d 21for the pigs fed the
0.5% clove treatment, we conducted a sec-
ond trial with a similar design but lower
levels of added cloves. Additionally, we
wanted to confirm the positive response
observed in pigs fed 0.5% cloves. 
In trial 2, pigs fed any of the added clove
treatments (0.125%, 0.25%, or 0.5%) had
similar ADG, ADFI, and 28-day weights
compared to those fed the negative control
diet (no in-feed antimicrobial).  In fact,
ADFI was decreased (P<0.05) for the d 0 to
21 period, and tended to be decreased
(P<0.09) for pigs fed the 0.25% and 0.5%
dietary clove treatments compared to pigs
fed the negative control diet.  Average daily
gain and the 21 d average weight were im-
proved  (P<0.05) for pigs fed the positive
control containing carbadox compared to the
negative control.  However, due to the
growth rate in the last 7 d of the trial, there
was no improvement (P>0.63) for the d 0 to
28 d period for the pigs fed the positive
control compared to those fed the negative
control diet. 
Pigs fed the positive control diet contain-
ing carbadox (50 g/ton) demonstrated im-
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provement in ADG from d 0 to 21 in both
trials. However, this improvement was not
maintained through 28 days in the second
trial. Interestingly, F/G differences were not
observed between pigs fed the antimicrobial
containing positive and negative control
treatments in either trial.  The improvements
in ADG from d 0 to 21for the pigs fed the
0.5% dietary clove treatment in the initial
trial were not repeated in the second evalua-
tion. The lack of repeatability is not under-
stood at this time.
In conclusion, substituting graded levels
of cloves provided inconsistent results from
d 0 to 21 post-weaning, and no benefits
through 28 days after weaning.  Further
research is warranted to evaluate the fac-
tor(s) in spices such as cloves that may affect
pig growth performance.
Table 2.  Growth Performance Effects of Feeding Cloves Post-Weaning (Trial 1 Data)
Control Clove, %
Item  Negatived Positivee 0.5 1.0 2.0 SEM
d 0 to 21
   ADG, lb 0.73a 0.83b 0.82b 0.74a,b 0.66a 0.03
   ADFI, lb 0.97b,c 1.06c 1.03c 0.88a,b 0.83a 0.03
   F/G 1.33 1.28 1.25 1.26 1.26 0.02
d 0 to 28
   ADG 0.90b 0.99c 0.97b,c 0.89a,b 0.83a 0.03
   ADFI 1.22b 1.32c 1.27b,c 1.19b 1.09a 0.03
   F/G 1.35 1.33 1.32 1.33 1.33 0.02
Avg. Weight, lb
   d 0 13.9 13.9 13.9 13.9 13.9 0.03
   d 21 29.2a,b 31.3c 31.1b,c 29.3a,b 27.8a 0.67
   d 28 39.2b 41.7c 40.9b.c 38.9a,b 37.04a 0.75
a,b,cMeans in the same row without a common superscript letter differ (P<0.05).
dNo in-feed antimicrobial.
eContained 55 ppm carbadox (Mecadox).
Table 3.  Growth Performance Effects of Feeding Cloves Post-Weaning (Trial 2 Data)
Control Clove, %
Item  Negativec  Positived 0.125 0.25 0.50 SEM
d 0 to 21
   ADG, lb 0.74a 0.81b 0.75a,b 0.69a 0.73a 0.023
   ADFI, lb 0.98a 1.00a 0.95a,b 0.87b 0.89b 0.030
   F/G 1.34 1.24 1.27 1.27 1.23 0.030
d 0 to 28
   ADG, lb 0.91a,b 0.94a 0.91a,b 0.85b 0.87b 0.022
   ADFI, lb 1.27a,b 1.29a 1.24a,b 1.15b 1.18b 0.034
   F/G 1.39 1.37 1.36 1.36 1.35 0.023
Weight, lb
   d 0 13.9 13.9 13.9 13.9 13.9 0.02
   d 21 29.4b 30.8a 29.6a,b 28.4b 29.2b 0.47
   d 28 39.4a,b 40.3a 39.3a,b 37.6b 38.3b 0.61
a,bMeans in the same row without a common superscript letter differ (P<0.05).
cNo in-feed antimicrobial.
dContained 55 ppm carbadox (Mecadox).
